Coinfection with SARS-CoV-2 and influenza A virus

BMJ Case Rep. 2020 Jul 1;13(7):e236812. doi: 10.1136/bcr-2020-236812.

Abstract

Since December 2019, coronavirus disease 2019 (COVID-19) has been an international public health emergency. The possibility of COVID-19 should be considered primarily in patients with new-onset fever or respiratory tract symptoms. However, these symptoms can occur with other viral respiratory illnesses. We reported a case of severe acute respiratory syndrome coronavirus 2 and influenza A virus coinfection. During the epidemic, the possibility of COVID-19 should be considered regardless of positive findings for other pathogens.

Keywords: infectious diseases; respiratory medicine.

Publication types

  • Case Reports

MeSH terms

  • Amides / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Antiviral Agents / therapeutic use
  • Betacoronavirus / isolation & purification*
  • COVID-19
  • Coinfection
  • Coronavirus Infections / complications*
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / drug therapy
  • Diagnosis, Differential
  • Glucocorticoids / therapeutic use
  • Humans
  • Influenza A virus / isolation & purification*
  • Influenza, Human / complications*
  • Influenza, Human / diagnosis*
  • Influenza, Human / economics
  • Lung / diagnostic imaging
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / drug therapy
  • Pregnenediones / therapeutic use
  • Pyrazines / therapeutic use
  • Radiography
  • Real-Time Polymerase Chain Reaction
  • SARS-CoV-2

Substances

  • Amides
  • Anti-Bacterial Agents
  • Antiviral Agents
  • Glucocorticoids
  • Pregnenediones
  • Pyrazines
  • favipiravir
  • ciclesonide